EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
Emily Capone(University of Chieti-Pescara), Gianluca Sala(University of Chieti-Pescara)
Cited by 28
Related Papers
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma
|Journal of Controlled Release|2018|38
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
|Oncotarget|2015|36
Extracellular <scp>LGALS3BP</scp> : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
|Molecular Oncology|2023|36
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer
|Oncology Reports|2020|12
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth
|Journal of Translational Medicine|2025|7